APA (7th ed.) Citation

Gellert, J., Jäkel, A., Danielczyk, A., Goletz, C., Lischke, T., Flechner, A., . . . Kehler, P. (2024). GT-00AxIL15, a Novel Tumor-Targeted IL-15-Based Immunocytokine for the Treatment of TA-MUC1-Positive Solid Tumors: Preclinical In Vitro and In Vivo Pharmacodynamics and Biodistribution Studies. International Journal of Molecular Sciences, 25(3), 1406. https://doi.org/10.3390/ijms25031406

Chicago Style (17th ed.) Citation

Gellert, Johanna, Anika Jäkel, Antje Danielczyk, Christoph Goletz, Timo Lischke, Anke Flechner, Laura Dix, Alexandra Günzl, and Patrik Kehler. "GT-00AxIL15, a Novel Tumor-Targeted IL-15-Based Immunocytokine for the Treatment of TA-MUC1-Positive Solid Tumors: Preclinical In Vitro and In Vivo Pharmacodynamics and Biodistribution Studies." International Journal of Molecular Sciences 25, no. 3 (2024): 1406. https://doi.org/10.3390/ijms25031406.

MLA (9th ed.) Citation

Gellert, Johanna, et al. "GT-00AxIL15, a Novel Tumor-Targeted IL-15-Based Immunocytokine for the Treatment of TA-MUC1-Positive Solid Tumors: Preclinical In Vitro and In Vivo Pharmacodynamics and Biodistribution Studies." International Journal of Molecular Sciences, vol. 25, no. 3, 2024, p. 1406, https://doi.org/10.3390/ijms25031406.